How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

被引:248
|
作者
Pieske, Burkert [1 ,2 ,3 ,4 ]
Tschoepe, Carsten [1 ,2 ,5 ]
de Boer, Rudolf A. [6 ]
Fraser, Alan G. [7 ]
Anker, Stefan D. [1 ,2 ,5 ,8 ]
Donal, Erwan [9 ]
Edelmann, Frank [1 ,2 ]
Fu, Michael [10 ]
Guazzi, Marco [11 ,12 ]
Lam, Carolyn S. P. [13 ,14 ,15 ]
Lancellotti, Patrizio [16 ]
Melenovsky, Vojtech [17 ]
Morris, Daniel A. [1 ]
Nagel, Eike [18 ,19 ]
Pieske-Kraigher, Elisabeth [1 ]
Ponikowski, Piotr [20 ]
Solomon, Scott D. [21 ]
Vasan, Ramachandran S. [22 ]
Rutten, Frans H. [23 ]
Voors, Adriaan A. [6 ]
Ruschitzka, Frank [24 ]
Paulus, Walter J. [25 ]
Seferovic, Petar [26 ]
Filippatos, Gerasimos [27 ,28 ,29 ]
机构
[1] Charite Univ Med Berlin, Campus Virchow Klinikum, Dept Internal Med & Cardiol, Berlin, Germany
[2] German Ctr Cardiovasc Res DZHK, Partner Site, Berlin, Germany
[3] German Heart Inst, Dept Internal Med & Cardiol, Berlin, Germany
[4] BIH, Berlin, Germany
[5] Charite, BIH, Ctr Regenerat Therapies BCRT, Berlin, Germany
[6] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[7] Cardiff Univ, Sch Med, Cardiff, Wales
[8] UMG, Dept Cardiol & Pneumol, Gottingen, Germany
[9] Univ Rennes 1, CHU Rennes LTSI, Cardiol & CIC, IT1414,INSERM 1099, Rennes, France
[10] Sahlgrens Univ Hosp, Dept Med, Cardiol Sect, Gothenburg, Sweden
[11] Univ Milan, Dept Biomed Sci Hlth, IRCCS, Milan, Italy
[12] IRCCS Policlin, Dept Cardiol, Milan, Italy
[13] Natl Heart Ctr, Singapore, Singapore
[14] Duke Natl Univ, Singapore, Singapore
[15] Univ Med Ctr Groningen, Groningen, Netherlands
[16] CHU Sart Tilman, Univ Liege Hosp, GIGA Cardiovasc Sci, Heart Valve Clin,Dept Cardiol, Liege, Belgium
[17] Inst Clin & Expt Med IKEM, Prague, Czech Republic
[18] Univ Hosp Frankfurt, Inst Expt & Translat Cardiovasc Imaging, Frankfurt, Germany
[19] German Ctr Cardiovasc Res DZHK, Partner Site Frankfurt, Frankfurt, Germany
[20] Med Univ, Clin Mil Hosp, Wroclaw, Poland
[21] Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA
[22] Boston Univ, Sch Med, Dept Med, Sect Prevent Med & Epidemiol & Cardiovasc Med, Boston, MA 02118 USA
[23] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[24] Univ Hosp Zurich, Univ Heart Ctr, Zurich, Switzerland
[25] Univ Amsterdam, Dept Physiol & Amsterdam Cardiovasc Sci, Med Ctr, Amsterdam, Netherlands
[26] Univ Belgrade, Sch Med, Med Ctr, Belgrade, Serbia
[27] Natl & Kapodistrian Univ Athens, Sch Med, Dept Cardiol, Athens, Greece
[28] Univ Hosp Attikon, Athens, Greece
[29] Univ Cyprus, Sch Med, Nicosia, Cyprus
关键词
Heart failure; HFpEF; Diagnosis; Echocardiography; Biomarkers; Natriuretic peptides; Exercise echocardiography; VENTRICULAR DIASTOLIC FUNCTION; CARDIOVASCULAR MAGNETIC-RESONANCE; LEFT ATRIAL VOLUME; SPECKLE TRACKING ECHOCARDIOGRAPHY; NATRIURETIC PEPTIDE LEVELS; GUANYLATE-CYCLASE STIMULATOR; IMPAIRED SYSTOLIC FUNCTION; CAPILLARY WEDGE PRESSURE; AMERICAN SOCIETY; PULMONARY-HYPERTENSION;
D O I
10.1002/ejhf.1741
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Making a firm diagnosis of chronic heart failure with preserved ejection fraction (HFpEF) remains a challenge. We recommend a new stepwise diagnostic process, the 'HFA-PEFF diagnostic algorithm'. Step 1 (P=Pre-test assessment) is typically performed in the ambulatory setting and includes assessment for heart failure symptoms and signs, typical clinical demographics (obesity, hypertension, diabetes mellitus, elderly, atrial fibrillation), and diagnostic laboratory tests, electrocardiogram, and echocardiography. In the absence of overt non-cardiac causes of breathlessness, HFpEF can be suspected if there is a normal left ventricular (LV) ejection fraction, no significant heart valve disease or cardiac ischaemia, and at least one typical risk factor. Elevated natriuretic peptides support, but normal levels do not exclude a diagnosis of HFpEF. The second step (E: Echocardiography and Natriuretic Peptide Score) requires comprehensive echocardiography and is typically performed by a cardiologist. Measures include mitral annular early diastolic velocity (e '), LV filling pressure estimated using E/e ', left atrial volume index, LV mass index, LV relative wall thickness, tricuspid regurgitation velocity, LV global longitudinal systolic strain, and serum natriuretic peptide levels. Major (2 points) and Minor (1 point) criteria were defined from these measures. A score >= 5 points implies definite HFpEF; <= 1 point makes HFpEF unlikely. An intermediate score (2-4 points) implies diagnostic uncertainty, in which case Step 3 (F-1: Functional testing) is recommended with echocardiographic or invasive haemodynamic exercise stress tests. Step 4 (F-2: Final aetiology) is recommended to establish a possible specific cause of HFpEF or alternative explanations. Further research is needed for a better classification of HFpEF.
引用
收藏
页码:391 / 412
页数:22
相关论文
共 50 条
  • [31] The H2FPEF and HFA-PEFF algorithms for predicting exercise intolerance and abnormal hemodynamics in heart failure with preserved ejection fraction
    Amanai, Shiro
    Harada, Tomonari
    Kagami, Kazuki
    Yoshida, Kuniko
    Kato, Toshimitsu
    Wada, Naoki
    Obokata, Masaru
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [32] Reflection of the new HFA-PEFF scoring system into clinical practice as compared to HFpEF diagnostic criteria of the ESC-HFA 2016 heart failure guidelines
    Murat, S.
    Cavusoglu, Y.
    Yalvac, H. E.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 29 - 29
  • [33] Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC)
    Mullens, Wilfried
    Dauw, Jeroen
    Gustafsson, Finn
    Mebazaa, Alexandre
    Steffel, Jan
    Witte, Klaus K.
    Delgado, Victoria
    Linde, Cecilia
    Vernooy, Kevin
    Anker, Stefan D.
    Chioncel, Ovidiu
    Milicic, Davor
    Hasenfuss, Gerd
    Ponikowski, Piotr
    Stephan von Bardeleben, Ralph
    Koehler, Friedrich
    Ruschitzka, Frank
    Damman, Kevin
    Schwammenthal, Ehud
    Testani, Jeffrey M.
    Zannad, Faiez
    Boehm, Michael
    Cowie, Martin R.
    Dickstein, Kenneth
    Jaarsma, Tiny
    Filippatos, Gerasimos
    Volterrani, Maurizio
    Thum, Thomas
    Adamopoulos, Stamatis
    Cohen-Solal, Alain
    Moura, Brenda
    Rakisheva, Amina
    Ristic, Arsen
    Bayes-Genis, Antoni
    Van Linthout, Sophie
    Tocchetti, Carlo Gabriele
    Savarese, Gianluigi
    Skouri, Hadi
    Adamo, Marianna
    Amir, Offer
    Yilmaz, Mehmet Birhan
    Simpson, Maggie
    Tokmakova, Mariya
    Gonzalez, Arantxa
    Piepoli, Massimo
    Seferovic, Petar
    Metra, Marco
    Coats, Andrew J. S.
    Rosano, Giuseppe M. C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (02) : 483 - 501
  • [34] Can Catheter Ablation Be Effective in Patients With Persistent Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction Diagnosed Using HFA-PEFF Score?
    Nakasuka, Kosuke
    Oishi, Yukako
    Tsuruta, Yoshiro
    Ishida, Marina
    Kawada, Yu
    Mori, Kento
    Kikuchi, Shohei
    Kitada, Shuichi
    Goto, Toshihiko
    Seo, Yoshihiro
    CIRCULATION, 2022, 146
  • [35] Cardiopulmonary response to exercise and heart failure with preserved ejection fraction risk: a comparative analysis of HFA-PEFF and H2FPEF scores
    Lazzeroni, D.
    Marchini, C.
    Centorbi, C. S.
    Moderato, L.
    Brambilla, L.
    Bini, M.
    Guazzi, E.
    Magnani, G.
    Aschieri, D.
    Piepoli, M.
    Nicolini, F.
    Coruzzi, P.
    EUROPEAN HEART JOURNAL, 2022, 43 : 794 - 794
  • [36] Evaluation the value of H2FPEF score and HFA-PEFF step E score in the diagnosis of heart failure with preserved ejection fraction
    Wang, Zhuolin
    Fang, Jun
    Hong, Huashan
    ACTA CARDIOLOGICA, 2023, 78 (07) : 790 - 795
  • [37] Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC)
    Meijers, Wouter C.
    Bayes-Genis, Antoni
    Mebazaa, Alexandre
    Bauersachs, Johann
    Cleland, John G. F.
    Coats, Andrew J. S.
    Januzzi, James L.
    Maisel, Alan S.
    McDonald, Kenneth
    Mueller, Thomas
    Richards, A. Mark
    Seferovic, Petar
    Mueller, Christian
    de Boer, Rudolf A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (10) : 1610 - 1632
  • [38] Comparing the Diagnostic Performance of ORIGINAL INVESTIGATION HFA-PEFF and H2FPEF Scoring Systems in Heart Failure with Preserved Ejection Fraction Patients: Insights from the APOLLON Registry
    Mert, Gurbet Ozge
    Ozlek, Buelent
    Ozlek, Eda
    Agus, Hicaz Zencirkiran
    Tekinalp, Mehmet
    Kahraman, Serkan
    Cil, Cem
    Celik, Oguzhan
    Basaran, Ozcan
    Dogan, Volkan
    Kaya, Bedri Caner
    Rencuezogullari, Ibrahim
    Osken, Altug
    Bekar, Lutfu
    Cakir, Mustafa Ozan
    Celik, Yunus
    Sancar, Kadriye Memic
    Sevinc, Samet
    Biteker, Murat
    Mert, Kadir Ugur
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2023, 27 (09): : 539 - 548
  • [39] How to diagnose heart failure with preserved ejection fraction
    Istratoaie, Sabina
    Gargani, Luna
    Popescu, Bogdan A.
    Thomas, Liza
    Voigt, Jens-Uwe
    Donal, Erwan
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2024, 25 (11) : 1505 - 1516
  • [40] Performance of the H2FPEF and the HFA-PEFF scores for the diagnosis of heart failure with preserved ejection fraction in Japanese patients: A report from the Japanese multicenter registry
    Tada, Atsushi
    Nagai, Toshiyuki
    Omote, Kazunori
    Iwano, Hiroyuki
    Tsujinaga, Shingo
    Kamiya, Kiwamu
    Konishi, Takao
    Sato, Takuma
    Komoriyama, Hirokazu
    Kobayashi, Yuta
    Takenaka, Sakae
    Mizuguchi, Yoshifumi
    Sato, Tomoya
    Yamamoto, Kazuhiro
    Yoshikawa, Tsutomu
    Saito, Yoshihiko
    Anzai, Toshihisa
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 342 : 43 - 48